2 FTSE 100 stocks I’d buy in February and 1 I’d sell

Here are some of the stocks I’m buying and selling this month.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Every investor loves dividends. They’re the bread and butter of investing. Studies have shown that if you’re not investing with dividends in mind, you stand no chance of matching the market’s returns as around 50% of these come from reinvested dividends. 

That’s why I’m always hunting out the best dividend stocks and trying to avoid the worst, those dividend stocks that are clearly pursuing an unsustainable dividend policy.

Two top dividend picks 

BP (LSE: BP) and GlaxoSmithKline (LSE: GSK) are two dividend champions that look extremely attractive right now. Shares in these two companies both offer a dividend yield of 5% or more, and as we head into 2017, the outlook for both companies is improving.

This time last year, the price of Brent crude oil was around $41 a barrel. Today, the price is more than 25% higher at $54 a barrel, which is great news for BP. Over the past year, the company has been cutting costs to deal with the low oil price environment, and over the next 12 months, these actions should begin to pay off. 

Indeed, during 2017 City analysts expect the company’s earnings per share to grow by 153% and further earnings per share growth of 19% is pencilled-in for 2018. Based on these figures, the shares are trading at a 2017 forward P/E of 14.9 and support a dividend yield of 6.6%. 

Like BP, analysts are predicting strong earnings per share growth for Glaxo during 2017. Growth of 11% is pencilled-in for the year taking earnings to 112p, the highest level since 2012. Based on these estimates the shares are trading at a forward P/E of 14 and support a dividend yield of 5.2%. By 2017, Glaxo’s dividend payout will be covered 1.5 times by earnings per share.

One stock to avoid 

In comparison to Glaxo and BP, EasyJet (LSE: EZJ) looks to me to be a company to avoid during 2017. EasyJet’s advantage over its peers used to be the carrier’s low-cost model. However, over the past few years, this economic benefit has disappeared. 

As a result, City analysts are predicting a 28% decline in earnings per share for the fiscal year to 30 September 2017. These declines follow a 22% fall in earnings per share for 2016. For the year ending 30 September 2017, City analysts expect EasyJet report a pre-tax profit of £385m and earnings per share of 78p. For some comparison, two years ago EasyJet reported a record pre-tax profit of £686m and earnings per share of 139p. 

Even though the company’s dividend yield of 5.7%, is covered twice by earnings per share at present, this payout could come under pressure if earnings continue to decline. Shares in EasyJet currently trade at a forward P/E of 12.2, which looks appropriate considering the group’s rapidly declining profits. All in all, considering EasyJet’s flagging growth it may be best to avoid the company for the time being.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Rupert Hargreaves owns shares of GlaxoSmithKline. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. The Motley Fool UK has recommended BP. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

With the FTSE 100 soaring, here are 2 quality shares I’d buy today

This Fool's focusing on FTSE 100 shares as he looks to add to his holdings. Here are two in particular…

Read more »

Smart young brown businesswoman working from home on a laptop
Investing Articles

Is the Lloyds share price the biggest bargain for investors right now?

The Lloyds share price is rising but this Fool still thinks it's a bargain. Here's why he thinks investors should…

Read more »

Silhouette of a bull standing on top of a landscape with the sun setting behind it
Investing Articles

Why the Experian share price is soaring after Q4 results

The Experian share price is at all-time highs after the company’s latest trading update. But does 6% revenue growth justify…

Read more »

Young Black woman using a debit card at an ATM to withdraw money
Investing Articles

Best FTSE 100 bank shares right now: Lloyds or HSBC?

This Fool is wondering which of these FTSE 100 bank stocks look like a better buy for his ISA today.…

Read more »

Growth Shares

This out-of-favour UK growth stock could rise 89%, according to City analysts

This growth stock has been absolutely crushed over the last 12 months or so. But analysts at Deutsche Bank are…

Read more »

Investing Articles

This company could be the answer to my passive income goals

Building a passive income through dividend-paying stocks can be a real game changer. I like what I see with this…

Read more »

Investing Articles

A 7.8% yield and growing! Is the Imperial Brands dividend a passive income bargain?

The Imperial Brands dividend is growing -- and the tobacco company already offers a juicy yield compared to many FTSE…

Read more »

Middle-aged black male working at home desk
Investing Articles

Imperial Brands’ share price is on fire! Time to buy following HY results?

The Imperial Brands share price is flying right now! Is the FTSE 100 cigarette giant starting to break out of…

Read more »